The World Health Organization defines?pharmacovigilance?(PV) as "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem."
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Pharmacovigilance (PV) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)
Market Segment by Product Application
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Pharmacovigilance (PV) consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Pharmacovigilance (PV) market by identifying its various subsegments.
3.Focuses on the key global Pharmacovigilance (PV) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Pharmacovigilance (PV) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Pharmacovigilance (PV) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Pharmacovigilance (PV) Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Pharmacovigilance (PV) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Pharmacovigilance (PV) Segment by Type
2.1.1 Contract Research Organizations (CROs)
2.1.2 Business Process Outsourcing (BPOs)
2.2 Market Analysis by Application
2.2.1 Premarketing Clinical Trial
2.2.2 Post-marketing Clinical Practice
2.2.3 Other
2.3 Global Pharmacovigilance (PV) Market Comparison by Regions (2017-2027)
2.3.1 Global Pharmacovigilance (PV) Market Size (2017-2027)
2.3.2 North America Pharmacovigilance (PV) Status and Prospect (2017-2027)
2.3.3 Europe Pharmacovigilance (PV) Status and Prospect (2017-2027)
2.3.4 China Pharmacovigilance (PV) Status and Prospect (2017-2027)
2.3.5 Japan Pharmacovigilance (PV) Status and Prospect (2017-2027)
2.3.6 Southeast Asia Pharmacovigilance (PV) Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Pharmacovigilance (PV) Industry Impact
2.5.1 Pharmacovigilance (PV) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Pharmacovigilance (PV) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Pharmacovigilance (PV) Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Pharmacovigilance (PV) Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Pharmacovigilance (PV) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Pharmacovigilance (PV) Manufacturer Market Share
3.5 Top 10 Pharmacovigilance (PV) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Pharmacovigilance (PV) Market
3.7 Key Manufacturers Pharmacovigilance (PV) Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Pharmacovigilance (PV) Industry Key Manufacturers
4.1 Accenture
4.1.1 Compan Detail
4.1.2 Accenture Pharmacovigilance (PV) Product Introduction, Application and Specification
4.1.3 Accenture 181 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Accenture News
4.2 C3i Solutions
4.2.1 Compan Detail
4.2.2 C3i Solutions Pharmacovigilance (PV) Product Introduction, Application and Specification
4.2.3 C3i Solutions Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Accenture News
4.3 Clintec
4.3.1 Compan Detail
4.3.2 Clintec Pharmacovigilance (PV) Product Introduction, Application and Specification
4.3.3 Clintec Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Clintec News
4.4 Covance
4.4.1 Compan Detail
4.4.2 Covance Pharmacovigilance (PV) Product Introduction, Application and Specification
4.4.3 Covance Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Covance News
4.5 Deloitte Touche Tohmatsu Limited
4.5.1 Compan Detail
4.5.2 Covance Pharmacovigilance (PV) Product Introduction, Application and Specification
4.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Deloitte Touche Tohmatsu Limited News
4.6 ELC Group
4.6.1 Compan Detail
4.6.2 ELC Group Pharmacovigilance (PV) Product Introduction, Application and Specification
4.6.3 ELC Group Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 ELC Group News
4.7 Ergomed
4.7.1 Compan Detail
4.7.2 Ergomed Pharmacovigilance (PV) Product Introduction, Application and Specification
4.7.3 Ergomed Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 iGATE Corporation
4.8.1 Compan Detail
4.8.2 iGATE Corporation Pharmacovigilance (PV) Product Introduction, Application and Specification
4.8.3 iGATE Corporation Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 iGATE Corporation News
4.9 iMED Global Corporation
4.9.1 Compan Detail
4.9.2 iMED Global Corporation Pharmacovigilance (PV) Product Introduction, Application and Specification
4.9.3 iMED Global Corporation Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 iMED Global Corporation News
4.10 IQVIA
4.10.1 Compan Detail
4.10.2 IQVIA Pharmacovigilance (PV) Product Introduction, Application and Specification
4.10.3 IQVIA Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 IQVIA News
4.11 MarksMan Healthcare
4.11.1 Compan Detail
4.11.2 MarksMan Healthcare Pharmacovigilance (PV) Product Introduction, Application and Specification
4.11.3 MarksMan Healthcare Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 MarksMan Healthcare News
4.12 Medpace Holdings
4.12.1 Compan Detail
4.12.2 Medpace Holdings Pharmacovigilance (PV) Product Introduction, Application and Specification
4.12.3 Medpace Holdings Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Medpace Holdings News
4.13 Novartis
4.13.1 Company Details
4.13.2 Novartis Pharmacovigilance (PV) Product Introduction, Application and Specification
4.13.3 Novartis Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Novartis News
4.14 Oracle Corporation
4.14.1 Compan Detail
4.14.2 Oracle Corporation Pharmacovigilance (PV) Product Introduction, Application and Specification
4.14.3 Oracle Corporation Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Oracle Corporation News
4.15 Parexel
4.15.1 Compan Detail
4.15.2 Parexel Pharmacovigilance (PV) Product Introduction, Application and Specification
4.15.3 Parexel Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Parexel News
4.16 PharmInvent
4.16.1 Compan Detail
4.16.2 PharmInvent Pharmacovigilance (PV) Product Introduction, Application and Specification
4.16.3 PharmInvent Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 PharmInvent News
4.17 PrimeVigilance
4.17.1 Compan Detail
4.17.2 PrimeVigilance Pharmacovigilance (PV) Product Introduction, Application and Specification
4.17.3 PrimeVigilance Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 PrimeVigilance News
4.18 Pure Drug Safety
4.18.1 Compan Detail
4.18.2 Pure Drug Safety Pharmacovigilance (PV) Product Introduction, Application and Specification
4.18.3 Pure Drug Safety Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Pure Drug Safety News
4.19 Sciformix
4.19.1 Compan Detail
4.19.2 Sciformix Pharmacovigilance (PV) Product Introduction, Application and Specification
4.19.3 Sciformix Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Sciformix News
4.20 SIRO Clinpharm
4.20.1 Compan Detail
4.20.2 SIRO Clinpharm Pharmacovigilance (PV) Product Introduction, Application and Specification
4.20.3 SIRO Clinpharm Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 SIRO Clinpharm News
4.21 Symogen
4.21.1 Compan Detail
4.21.2 Symogen Pharmacovigilance (PV) Product Introduction, Application and Specification
4.21.3 Symogen Pharmacovigilance (PV) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.21.4 Main Business Overview
4.21.5 Symogen News
5 Global Pharmacovigilance (PV) Market Segment by Big Type
5.1 Global Pharmacovigilance (PV) Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Pharmacovigilance (PV) Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Pharmacovigilance (PV) Revenue and Market Share by Big Type (2017-2022)
5.2 Contract Research Organizations (CROs) Sales Growth Rate and Price
5.2.1 Global Contract Research Organizations (CROs) Sales Growth Rate (2017-2022)
5.2.2 Global Contract Research Organizations (CROs) Price (2017-2022)
5.3 Business Process Outsourcing (BPOs) Sales Growth Rate and Price
5.3.1 Global Business Process Outsourcing (BPOs) Sales Growth Rate (2017-2022)
5.3.2 Global Business Process Outsourcing (BPOs) Price (2017-2022)
6 Global Pharmacovigilance (PV) Market Segment by Big Application
6.1 Global Pharmacovigilance (PV) Sales Market Share by Big Application (2017-2022)
6.2 Premarketing Clinical Trial Sales Growth Rate (2017-2022)
6.3 Post-marketing Clinical Practice Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Pharmacovigilance (PV) Forecast
7.1 Global Pharmacovigilance (PV) Revenue, Sales and Growth Rate (2022-2027)
7.2 Pharmacovigilance (PV) Market Forecast by Regions (2022-2027)
7.2.1 North America Pharmacovigilance (PV) Market Forecast (2022-2027)
7.2.2 Europe Pharmacovigilance (PV) Market Forecast (2022-2027)
7.2.3 China Pharmacovigilance (PV) Market Forecast (2022-2027)
7.2.4 Japan Pharmacovigilance (PV) Market Forecast (2022-2027)
7.2.5 Southeast Asia Pharmacovigilance (PV) Market Forecast (2022-2027)
7.2.6 Other Regions Pharmacovigilance (PV) Market Forecast (2022-2027)
7.3 Pharmacovigilance (PV) Market Forecast by Type (2022-2027)
7.3.1 Global Pharmacovigilance (PV) Sales Forecast by Type (2022-2027)
7.3.2 Global Pharmacovigilance (PV) Market Share Forecast by Type (2022-2027)
7.4 Pharmacovigilance (PV) Market Forecast by Application (2022-2027)
7.4.1 Global Pharmacovigilance (PV) Sales Forecast by Application (2022-2027)
7.4.2 Global Pharmacovigilance (PV) Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Pharmacovigilance (PV) Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Pharmacovigilance (PV) Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Pharmacovigilance (PV)
Figure Market Concentration Ratio and Market Maturity Analysis of Pharmacovigilance (PV)
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Pharmacovigilance (PV) Market Size by Big Type
Figure Global Market Share of Pharmacovigilance (PV) by Big Type in 2021
Figure Contract Research Organizations (CROs) Picture (2017-2022)
Global Pharmacovigilance (PV) Market Size by Big Application
Table Global Pharmacovigilance (PV) Market Size by Application
Figure Global Pharmacovigilance (PV) Market Share by Big Application in 2021
Figure Premarketing Clinical Trial Picture
Figure Post-marketing Clinical Practice Picture
Figure Other Picture
Table Global Pharmacovigilance (PV) Comparison by Regions (M USD) ?2017-2027?
Figure Global Pharmacovigilance (PV) Market Size (Million US$) (2017-2027)
Figure North America Pharmacovigilance (PV) Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Pharmacovigilance (PV) Revenue (Million US$) Growth Rate (2017-2027)
Figure China Pharmacovigilance (PV) Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Pharmacovigilance (PV) Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Pharmacovigilance (PV) Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Pharmacovigilance (PV) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Pharmacovigilance (PV) Sales by Manufacturer (2017-2022)
Figure Global Pharmacovigilance (PV) Sales Market Share by Manufacturer in 2021
Table Global Pharmacovigilance (PV) Revenue by Manufacturer (2017-2022)
Figure Global Pharmacovigilance (PV) Revenue Market Share by Manufacturer in 2021
Table Global Pharmacovigilance (PV) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Pharmacovigilance (PV) Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Pharmacovigilance (PV) Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Pharmacovigilance (PV) Market
Table Key Manufacturers Pharmacovigilance (PV) Product Type
Table Mergers & Acquisitions Planning
Table Accenture Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Accenture
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table C3i Solutions Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of C3i Solutions
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table C3i Solutions Recent Development
Table Clintec Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Clintec
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Clintec Main Business
Table Clintec Recent Development
Table Covance Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Covance
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Covance Main Business
Table Covance Recent Development
Table Covance Main Business
Table Covance Recent Development
Table Deloitte Touche Tohmatsu Limited Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Deloitte Touche Tohmatsu Limited
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Deloitte Touche Tohmatsu Limited Main Business
Table Deloitte Touche Tohmatsu Limited Recent Development
Table ELC Group Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of ELC Group
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table ELC Group Main Business
Table ELC Group Recent Development
Table Ergomed Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Ergomed
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ergomed Main Business
Table Ergomed Recent Development
Table iGATE Corporation Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of iGATE Corporation
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table iGATE Corporation Main Business
Table iGATE Corporation Recent Development
Table iMED Global Corporation Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of iMED Global Corporation
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table iMED Global Corporation Main Business
Table iMED Global Corporation Recent Development
Table IQVIA Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of IQVIA
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table IQVIA Main Business
Table IQVIA Recent Development
Table MarksMan Healthcare Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of MarksMan Healthcare
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table MarksMan Healthcare Main Business
Table MarksMan Healthcare Recent Development
Table Medpace Holdings Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Medpace Holdings
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Medpace Holdings Main Business
Table Medpace Holdings Recent Development
Table Novartis Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Novartis
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Oracle Corporation Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Oracle Corporation
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Oracle Corporation Main Business
Table Oracle Corporation Recent Development
Table PharmInvent Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of PharmInvent
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table PharmInvent Main Business
Table PharmInvent Recent Development
Table PrimeVigilance Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of PrimeVigilance
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table PrimeVigilance Main Business
Table PrimeVigilance Recent Development
Table Pure Drug Safety Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Pure Drug Safety
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pure Drug Safety Main Business
Table Pure Drug Safety Recent Development
Table Sciformix Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Sciformix
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sciformix Main Business
Table Sciformix Recent Development
Table SIRO Clinpharm Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of SIRO Clinpharm
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table SIRO Clinpharm Main Business
Table SIRO Clinpharm Recent Development
Table Symogen Company Profile
Table Pharmacovigilance (PV) Product Introduction, Application and Specification of Symogen
Table Pharmacovigilance (PV) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Symogen Main Business
Table Symogen Recent Development
Figure Global Pharmacovigilance (PV) Sales and Growth Rate (2017-2022)
Figure Global Pharmacovigilance (PV) Revenue and Growth Rate (2017-2022)
Table Global Pharmacovigilance (PV) Sales by Regions (2017-2022)
Figure Global Pharmacovigilance (PV) Sales Market Share by Regions in 2021
Table Global Pharmacovigilance (PV) Revenue by Regions (2017-2022)
Figure Global Pharmacovigilance (PV) Revenue Market Share by Regions in 2021
Figure North America Pharmacovigilance (PV) Sales and Growth Rate (2017-2022)
Figure Europe Pharmacovigilance (PV) Sales and Growth Rate (2017-2022)
Figure China Pharmacovigilance (PV) Sales and Growth Rate (2017-2022)
Figure Japan Pharmacovigilance (PV) Sales and Growth Rate (2017-2022)
Figure Southeast Asia Pharmacovigilance (PV) Sales and Growth Rate (2017-2022)
Figure Other Regions Pharmacovigilance (PV) Sales and Growth Rate (2017-2022)
Table Global Pharmacovigilance (PV) Sales by Big Type (2017-2022)
Table Global Pharmacovigilance (PV) Sales Market Share by Big Type (2017-2022)
Figure Global Pharmacovigilance (PV) Sales Market Share by Big Type in 2019
Table Global Pharmacovigilance (PV) Revenue by Big Type (2017-2022)
Table Global Pharmacovigilance (PV) Revenue Market Share by Big Type (2017-2022)
Table Global Pharmacovigilance (PV) Revenue Market Share by Big Type in 2019
Figure Global Contract Research Organizations (CROs) Sales Growth Rate (2017-2022)
Figure Global Contract Research Organizations (CROs) Price (2017-2022)
Figure Global Business Process Outsourcing (BPOs) Sales Growth Rate (2017-2022)
Table Global Pharmacovigilance (PV) Sales by Big Application (2017-2022)
Table Global Pharmacovigilance (PV) Sales Market Share by Big Application (2017-2022)
Figure Global Pharmacovigilance (PV) Sales Market Share by Big Application in 2019
Figure Global Premarketing Clinical Trial Sales Growth Rate (2017-2022)
Figure Global Post-marketing Clinical Practice Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Pharmacovigilance (PV) Sales and Growth Rate (2022-2027)
Figure Global Pharmacovigilance (PV) Revenue and Growth Rate (2022-2027)
Table Global Pharmacovigilance (PV) Sales Forecast by Regions (2022-2027)
Table Global Pharmacovigilance (PV) Market Share Forecast by Regions (2022-2027)
Figure North America Sales Pharmacovigilance (PV) Market Forecast (2022-2027)
Figure Europe Sales Pharmacovigilance (PV) Market Forecast (2022-2027)
Figure China Sales Pharmacovigilance (PV) Market Forecast (2022-2027)
Figure Japan Sales Pharmacovigilance (PV) Market Forecast (2022-2027)
Figure Southeast Asia Sales Pharmacovigilance (PV) Market Forecast (2022-2027)
Figure Other Regions Sales Pharmacovigilance (PV) Market Forecast (2022-2027)
Table Global Pharmacovigilance (PV) Sales Forecast by Type (2022-2027)
Table Global Pharmacovigilance (PV) Market Share Forecast by Type (2022-2027)
Table Global Pharmacovigilance (PV) Sales Forecast by Application (2022-2027)
Table Global Pharmacovigilance (PV) Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharmacovigilance (PV)
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Pharmacovigilance (PV) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Pharmacovigilance (PV) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Pharmacovigilance (PV) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Pharmacovigilance (PV) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Pharmacovigilance (PV) Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Pharmacovigilance (PV) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Pharmacovigilance (PV) Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Pharmacovigilance (PV) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)